The safe and effective treatment for skin rejuvenation FEATURE 1 Limited volumising action of CaHA compared to Ellansé Colour distance maps * demonstrate the qualitative change in volume over time
Ellansé 1 • Yellow/red colour intensity shows volume increase from baseline, one year and two years post treatment • Volume increase of 50–150% over baseline ** • Ellansé’s smooth PCL microspheres 3 • U ndergo slow biodegradation • E mbed within collagen fibres to form a unique 3D scaffold for a sustained effect
CaHA 2 • Volume increases one month post treatment, with a decline and loss of volume at month 5 • Residual volume at month 5 of 4–35% † • CaHA microspheres breakdown within the body • C ontinuous decrease in particle size • Fragments form and shorter duration
Baseline Image
Post 1 year
Post 2 years
Baseline Image
Post 1 month
Post 5 months
Figure 1: 38-year-old patient. Total of 1.0ml on both malar areas
Figure 2: 45-year-old patient. Total of 1.5ml on both malar areas
*The colour scale shows green as baseline and any increase in volume manifests incrementally as yellow and red **Results from patients A–I, % volume increase at 2 years (A:90, B:100, C:150, D:80, E:50, F:150, G:150, H:140, I:90) † Results from patients (A–D), percentage residual volume at 5 months (A:4, B:7.5, C:35, D:10) 1. Angelo-Khattar M. Clin Cosmet Investig Dermatol. 2022;15:2895–2901; 2. Angelo-Khattar M. J Clin Cosmet Dermatol. 2021;5(2):2576–2826; 3. Christen M-O, Vercesi F. Clin Cosmet Investig Dermatol. 2020;13:31–48.
Features Before & After Results 1 2 3 Why Ellansé 1
Product Summary
Testimonies
MaiLi
Lanluma Ellansé Ellansé
PRODUCT COMPARISON
6
Made with FlippingBook Digital Publishing Software